Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Aflibercept biosimilar by Alvotech for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
Aflibercept biosimilar is under clinical development by Alvotech and currently in Phase III for Wet (Neovascular / Exudative) Macular Degeneration....
Aflibercept biosimilar by Celltrion for Age Related Macular Degeneration: Likelihood of Approval
Aflibercept biosimilar is under clinical development by Celltrion and currently in Pre-Registration for Age Related Macular Degeneration. According to GlobalData,...
Aflibercept biosimilar by Lupin for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
Aflibercept biosimilar is under clinical development by Lupin and currently in Phase III for Wet (Neovascular / Exudative) Macular Degeneration....